Intravenous Remifentanil Patient-controlled Analgesia (PCA) and Epidural Patient Controlled Epidural Analgesia (PCEA) for Labor Analgesia

Phase 4

Completed

• Conditions: Pain; Labor
• Interventions: Drug: Bupivacaine epidural; Drug: Remifentanil

• Registration Number: NCT00801047
• Lead Sponsor: Hadassah Medical Organization

Brief Summary

Women requesting analgesia do not always wish to receive a potent analgesic method, and may fear the risks of epidural analgesia.

Study Aim: To determine whether remifentanil is effective for labor analgesia when compared with standard treatment (epidural analgesia).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2008-12-02
• Study First Submitted QC: 2008-12-02
• Study First Posted: 2008-12-03
• Status Verified: 2010-02
• Study Start: 2010-02
• Primary Completion: 2012-07
• Study Completion: 2012-07
• Last Update Submitted: 2015-04-19
• Last Update Posted: 2015-04-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Bupivacaine epidural	Epidural group
2	Remifentanil	Remifentanil iv PCA

Primary Outcome Measures

Name	Time	Method
Primary analgesia end-point: VAS pain Score	1-6 hours

Trial Locations

Locations (1)

Hadassah Medical Organization; 🇮🇱 Jerusalem, Israel